Showing results (2081-2090 of 2,560) with videos related to

Sort By:
Pageof 256
Cancer|April 20, 2017
Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT studyJohn L Gore, Marguerite du Plessis, María Santiago-Jiménez, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 15, 2014
Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profilingS M Kurian, A N Williams, T Gelbart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Neoadjuvant Enzalutamide Prior to ProstatectomyBruce Montgomery, Maria S Tretiakova, Anthony M Joshua, et al.
The Journal of Clinical Investigation|July 31, 2019
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancerMark P Labrecque, Ilsa M Coleman, Lisha G Brown, et al.
Urology|August 2, 2008
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancerEdouard J Trabulsi, Richard K Valicenti, Alexandra L Hanlon, et al.
Clinical Genitourinary Cancer|November 8, 2020
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) ProgramLeonidas N Diamantopoulos, Sarah K Holt, Ali R Khaki, et al.
Journal of Synchrotron Radiation|May 5, 2021
Development of the Soft X-ray AGM-AGS RIXS beamline at the Taiwan Photon SourceA Singh, H Y Huang, Y Y Chu, et al.
Insect Molecular Biology|May 21, 2010
Comprehensive survey of developmental genes in the pea aphid, Acyrthosiphon pisum: frequent lineage-specific duplications and losses of developmental genesS Shigenobu, R D Bickel, J A Brisson, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune DiseasesBrian S Gerstenberger, Catherine Ambler, Eric P Arnold, et al.
The Journal of Urology|September 10, 2021
Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional CohortLauren Folgosa Cooley, Adaeze A Emeka, Travis J Meyers, et al.
Pageof 256